Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Issue : The Pharmaceutical Journal, 22/29 November 2014, Vol 293, No 7837/8

Sort by: Newest first Oldest first A-Z Z-A

  • Seasonal influenza vaccine is effective during regional or widespread outbreaks, study finds

    Review points to effectiveness of influenza vaccination Subscription

    18 NOV 2014 15:32

    Researchers have used “test-negative design” case-control studies to assess the effectiveness of seasonal influenza vaccine.

  • Ebola research projects receive £1.34m Subscription

    17 NOV 2014 17:12

    A hand-held device to test bodily fluids for the Ebola virus is among five new research projects announced by the UK government and the Wellcome Trust.

  • Micro-costing economic model to be used to assess costs of pharmacy service

    Micro-costing model used to assess costs of pharmacy service Subscription

    17 NOV 2014 17:07

    Researchers have used micro-costing to discover the cost of a medication review service in a care home given by a multidisciplinary team.

  • Thursday 27 November: Scotland Subscription

    17 NOV 2014 16:51

    Local practice forum event, ‘Are you using standards and guidance to ensure patient-centred professionalism in the delivery of care?’ The Gailes Restaurant, Marine Drive, Gailes, Ayrshire KA11 5AE. Event 6.30pm. Book via the RPS website.

  • Claire Liew with the pharmacy staff of St Walburg's Hospital in Tanzania where she volunteered as part of the Voluntary Service Overseas (VSO)

    Volunteering as a pharmacist in Tanzania Subscription

    17 NOV 2014 16:29 By Claire Liew

    Pharmacist Claire Liew spent 18 months volunteering at St Walburg’s hospital in Tanzania with Voluntary Service Overseas. Here, she describes what she learnt — and hints that her adventures abroad might not be over yet.

  • A “procedural error” has led to the annulment of Guido Rasi’s appointment to the position of executive director of the European Medicines Agency in 2011

    European Medicines Agency head steps down after “procedural error” Subscription

    17 NOV 2014 12:24

    Guido Rasi, the executive director of the European Medicines Agency (EMA), has been forced to step down after a “procedural error” in the process that appointed him to the position.

  • The World Health Organization (WHO) has issued guidelines on the use and access of naloxone to cut global deaths from opioid overdose

    Increased access to naloxone could cut global deaths from opioid overdose, says WHO Subscription

    17 NOV 2014 11:42 By John Zarocostas

    The World Health Organization has issued new guidelines to expand access to naloxone in an effort to reduce the number of deaths caused by overdoses of opioids.

  • November SMC decisions Subscription

    17 NOV 2014 9:52

    The Scottish Medicines Consortium (SMC) has published its November 2014 decisions on medicines to be used in NHS Scotland. Aflibercept (Eylea), daclatasvir (Daklinza), everolimus (Afinitor), ipilimumab (Yervoy) and saxagliptin (Onglyza) have been recommended for use in NHS Scotland. Pertuzumab (Perjeta) has been rejected for use in NHS Scotland. Further information is available on the SMC’s website in the

  • Havrix monodose supply constraint Subscription

    14 NOV 2014 15:58

    Due to manufacturing issues, UK availability of monovalent hepatitis A vaccine (Havrix Monodose) from GlaxoSmithKline (GSK) will be reduced during 2015. GSK will prioritise the remaining stock for GPs, hospitals, travel clinics and occupational health practitioners. Alternative hepatitis A vaccines are available from other manufacturers and combination hepatitis A vaccines remain available from GSK. Normal supply is expected to resume by early 2016. Further information on 0800 221441.

  • Drug Tariff update Subscription

    14 NOV 2014 15:55

    The Department of Health and National Assembly for Wales have agreed concessionary prices for the following items for November 2014 prescriptions: amantadine capsules 100mg, £19.80, amiloride tablets 5mg, £14.85, co-amilofruse tablets 2.5/20mg, £4.32, 5/40mg, £5.25, co-tenidone tablets 50/12.5mg, £3.55, 100/25mg, £3.55, cyclizine solution for injection ampoules 50mg/ml, £8.65, estriol cream 0.01%, £16.04, exemestane tablets 25mg, £37.95, fenofibrate micronised capsules 200mg, £12.00, ...

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.